Form D · Biotechnology
Rebiotix Inc.
Roseville, MN · CIK 0001532997
Offering snapshot reported Sep 5, 2017 · SEC filing
- Reported sold
- $8.52M Offering amount: $10M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 24, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 5, 2017 | Initial | $8,515,000 | No comparison | 29 | SEC filing |
| Jul 7, 2014 | Initial | $18,000,000 | No comparison | 6 | SEC filing |
| Nov 4, 2011 | Initial | $2,780,000 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-294071
Convertible promissory notes
Source: Form D, filed Sep 5, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Berman | Director |
| Greg Fluet | Executive |
| Lee Jones | Director, Executive |
| Erwin Kelen | Director |
| William Mc Guire | Director |
| Nancy Timm | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2660 Patton Road
Roseville, MN, 55113
Roseville, MN, 55113